Key facts
- Circadacare’s last known valuation is $3.7M (Apr 2025).
- It has raised $2.7M; the latest was Later Stage VC ($650K) in Apr 2025.
- Notable investors include Innovate UK, Northstar Ventures, Longitude Prize, Tomaž Slivnik.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Circadacare
- ·The full record, as it builds
Funding rounds
No funding rounds for Circadacare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Circadacare
Developer of an independent living technology designed to enhance wellness and promote autonomy. The company's product integrates circadian lighting with advanced artificial intelligence monitoring, offering features such as day and night cycle regulation, fall reduction, and behavioral tracking, enabling elderly individuals and those with dementia to improve their quality of life and maintain independence.
- Sector
- Healthcare
- HQ
- Newcastle upon Tyne, United Kingdom
- Founded
- 2020
- Employees
- 11
- Website
- circadacare.com/
- Ownership
- Privately Held (backing)
Circadacare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Circadacare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Circadacare in its N-PORT filings yet. We sweep new filings monthly.